Antibody data
- Antibody Data
- Antigen structure
- References [9]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 67557-1-Ig - Provider product page

- Provider
- Proteintech Group
- Product name
- USP15 antibody
- Antibody type
- Monoclonal
- Description
- USP15 antibody (Cat. #67557-1-Ig) is a mouse monoclonal antibody that shows reactivity with Human, Mouse, Rat and has been validated for the following applications: IHC, WB, ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Mouse
- Conjugate
- Unconjugated
- Isotype
- IgG
- Antibody clone number
- 1C9G3
- Vial size
- 20ul, 150ul
Submitted references SART3 promotes homologous recombination repair by stimulating DNA-RNA hybrids removal and DNA end resection.
Expression and role of deubiquitinating enzymes in thyroid carcinoma.
USP15 Drives NSCLC Progression and Chemoresistance, Potentially via Regulation of the U2-Type Spliceosomal Complex.
USP15 promotes the progression of papillary thyroid cancer by regulating HMGB1 stability through its deubiquitination.
Cell-Based Covalent-Capture Deubiquitinase Assay for Inhibitor Discovery.
USP15 regulates radiation-induced DNA damage and intestinal injury through K48-linked deubiquitination and stabilisation of ATM.
Proteostatic reactivation of the developmental transcription factor TBX3 drives BRAF/MAPK-mediated tumorigenesis.
Long non-coding RNA MFSD4A-AS1 promotes lymphangiogenesis and lymphatic metastasis of papillary thyroid cancer.
The deubiquitinating enzyme USP15 stabilizes ERα and promotes breast cancer progression.
Fu H, Huang M, Wu H, Zheng H, Gong Y, Xing L, Gong J, An R, Li Q, Jie X, Ma X, Tang TS, Guo C
Nature communications 2025 Mar 6;16(1):2244
Nature communications 2025 Mar 6;16(1):2244
Expression and role of deubiquitinating enzymes in thyroid carcinoma.
Huang M, Yan C, Ling R, Wang T
Briefings in functional genomics 2025 Jan 15;24
Briefings in functional genomics 2025 Jan 15;24
USP15 Drives NSCLC Progression and Chemoresistance, Potentially via Regulation of the U2-Type Spliceosomal Complex.
Chiu CC, Hsu SK, Liu W, Lin IL, Qiu W, Hsieh CH, Chou CK
Cancer medicine 2025 Aug;14(15):e71055
Cancer medicine 2025 Aug;14(15):e71055
USP15 promotes the progression of papillary thyroid cancer by regulating HMGB1 stability through its deubiquitination.
Wang SS, Ye DX, Wang B, Li MY, Zhao WX
Journal of Cancer 2024;15(9):2561-2572
Journal of Cancer 2024;15(9):2561-2572
Cell-Based Covalent-Capture Deubiquitinase Assay for Inhibitor Discovery.
Doleschal MN, Miller J, Jain S, Zakharov AV, Rai G, Simeonov A, Baljinnyam B, Zhuang Z
ACS pharmacology & translational science 2024 Sep 13;7(9):2827-2839
ACS pharmacology & translational science 2024 Sep 13;7(9):2827-2839
USP15 regulates radiation-induced DNA damage and intestinal injury through K48-linked deubiquitination and stabilisation of ATM.
Zhu R, Li M, Wang D, Liu C, Xie L, Yang Y, Gu X, Zhao K, Tian Y, Cai S
Molecular medicine (Cambridge, Mass.) 2024 Nov 9;30(1):205
Molecular medicine (Cambridge, Mass.) 2024 Nov 9;30(1):205
Proteostatic reactivation of the developmental transcription factor TBX3 drives BRAF/MAPK-mediated tumorigenesis.
Zhang Z, Wu Y, Fu J, Yu X, Su Y, Jia S, Cheng H, Shen Y, He X, Ren K, Zheng X, Guan H, Rao F, Zhao L
Nature communications 2024 May 15;15(1):4108
Nature communications 2024 May 15;15(1):4108
Long non-coding RNA MFSD4A-AS1 promotes lymphangiogenesis and lymphatic metastasis of papillary thyroid cancer.
Liu X, Zhang C, Wang X, Cui C, Cui H, Zhu B, Chen A, Zhang L, Xin J, Fu Q, Dionigi G, Sun H
Endocrine-related cancer 2023 Mar 1;30(3)
Endocrine-related cancer 2023 Mar 1;30(3)
The deubiquitinating enzyme USP15 stabilizes ERα and promotes breast cancer progression.
Xia X, Huang C, Liao Y, Liu Y, He J, Shao Z, Hu T, Yu C, Jiang L, Liu J, Huang H
Cell death & disease 2021 Mar 26;12(4):329
Cell death & disease 2021 Mar 26;12(4):329
No comments: Submit comment
No validations: Submit validation data